Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2019

28.03.2019 | Thoracic Oncology

Long-Term Outcomes After Surgical Resection for Pleural Dissemination of Thymoma

verfasst von: Kenji Kimura, MD, Ryu Kanzaki, MD, PhD, Toru Kimura, MD, PhD, Takashi Kanou, MD, PhD, Naoko Ose, MD, Soichiro Funaki, MD, PhD, Masato Minami, MD, PhD, Yasushi Shintani, MD, PhD, Meinoshin Okumura, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Cases of thymoma with pleural dissemination are occasionally encountered, and their management is difficult. Some reports have noted that surgical treatment for dissemination is effective, although the long-term results and clinical course details remain unclear. The current study investigated the short- and long-term outcomes of surgical resection of pleural dissemination.

Methods

A retrospective review examined the medical records for 38 patients who underwent surgical resection for pleural dissemination occurring synchronously with a primary thymoma or metachronously after complete surgical resection of a primary thymoma between 1996 and 2017 at the authors’ institution. Clinical characteristics and prognostic factors were analyzed.

Results

The patients were classified into synchronous (n = 21) and metachronous (n = 17) groups. The 10-year overall survival rate was 59% for the synchronous group and 88% for the metachronous group. The median follow-up period for all the patients was 61 months (range 4–225 months). No perioperative deaths occurred. For all the patients, the 5- and 10-year overall survival rates were respectively 91% and 82%, and the 5- and 10-year relapse-free survival rates were respectively 29% and 19%. A significantly worse prognosis was observed for patients 50 years of age or older than for those younger than 50 years (p = 0.02). For 13 patients who underwent repeat resection for pleural dissemination, the prognosis was better than for those without repeat resection (p < 0.01).

Conclusion

Surgical resection of thymoma with pleural disseminated nodules can be safely performed and provides a favorable long-term outcome. Repeat resection is considered to be effective for achieving a good prognosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Haniuda M, Kondo R, Numanami H, Makiuchi A, Machida A, Amano J. Recurrence of thymoma: clinicopathological features, reoperation, and outcome. J Surg Oncol. 2001;78:183–8.CrossRefPubMed Haniuda M, Kondo R, Numanami H, Makiuchi A, Machida A, Amano J. Recurrence of thymoma: clinicopathological features, reoperation, and outcome. J Surg Oncol. 2001;78:183–8.CrossRefPubMed
2.
Zurück zum Zitat Shinohara S, Hanagiri T, So T, et al. Results of surgical resection for patients with thymoma according to World Health Organization histology and Masaoka staging. Asian J Surg. 2012;35:144–8.CrossRefPubMed Shinohara S, Hanagiri T, So T, et al. Results of surgical resection for patients with thymoma according to World Health Organization histology and Masaoka staging. Asian J Surg. 2012;35:144–8.CrossRefPubMed
3.
Zurück zum Zitat Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg. 2003;76:878–84.CrossRefPubMed Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg. 2003;76:878–84.CrossRefPubMed
4.
Zurück zum Zitat Regnard J-F, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P. Results of re-resection for recurrent thymomas. Ann Thorac Surg. 1997;64:1593–8.CrossRefPubMed Regnard J-F, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P. Results of re-resection for recurrent thymomas. Ann Thorac Surg. 1997;64:1593–8.CrossRefPubMed
5.
Zurück zum Zitat Okumura M, Shiono H, Inoue M, et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to World Health Organization histologic classification system. J Surg Oncol. 2007;95:40–4.CrossRefPubMed Okumura M, Shiono H, Inoue M, et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to World Health Organization histologic classification system. J Surg Oncol. 2007;95:40–4.CrossRefPubMed
6.
Zurück zum Zitat Lucchi M, Davini F, Ricciardi R, et al. Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg. 2009;137:1185–9.CrossRefPubMed Lucchi M, Davini F, Ricciardi R, et al. Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg. 2009;137:1185–9.CrossRefPubMed
7.
Zurück zum Zitat Murakawa T, Karasaki T, Kitano K, et al. Invasive thymoma disseminated into the pleural cavity: mid-term results of surgical resection. Eur J Cardiothorac Surg. 2015;47:567–72.CrossRefPubMed Murakawa T, Karasaki T, Kitano K, et al. Invasive thymoma disseminated into the pleural cavity: mid-term results of surgical resection. Eur J Cardiothorac Surg. 2015;47:567–72.CrossRefPubMed
8.
Zurück zum Zitat Yano M, Sasaki H, Yukiue H, et al. Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules. World J Surg. 2009;33:1425–31.CrossRefPubMed Yano M, Sasaki H, Yukiue H, et al. Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules. World J Surg. 2009;33:1425–31.CrossRefPubMed
9.
Zurück zum Zitat Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.CrossRefPubMed Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.CrossRefPubMed
10.
Zurück zum Zitat Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma. Cancer. 2002;94:624–32.CrossRefPubMed Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma. Cancer. 2002;94:624–32.CrossRefPubMed
12.
Zurück zum Zitat Fabre D, Fadel E, Mussot S, et al. Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma. Eur J Cardiothorac Surg. 2011;39:e133–8.CrossRefPubMed Fabre D, Fadel E, Mussot S, et al. Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma. Eur J Cardiothorac Surg. 2011;39:e133–8.CrossRefPubMed
13.
Zurück zum Zitat Huang J, Rizk NP, Travis WD, et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg. 2007;134:1477–83; discussion 1483–1484. Huang J, Rizk NP, Travis WD, et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg. 2007;134:1477–83; discussion 1483–1484.
14.
Zurück zum Zitat Yang HC, Yoon YS, Kim HK, et al. En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas. J Cardiothorac Surg. 2011;6:28.CrossRefPubMedPubMedCentral Yang HC, Yoon YS, Kim HK, et al. En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas. J Cardiothorac Surg. 2011;6:28.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Okuda K, Yano M, Yoshino I, et al. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan. Ann Thorac Surg. 2014;97:1743–8.CrossRefPubMed Okuda K, Yano M, Yoshino I, et al. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan. Ann Thorac Surg. 2014;97:1743–8.CrossRefPubMed
16.
Zurück zum Zitat Marulli G, Margaritora S, Lucchi M, et al. Surgical treatment of recurrent thymoma: is it worthwhile? Eur J Cardiothorac Surg. 2016;49:327–32.CrossRefPubMed Marulli G, Margaritora S, Lucchi M, et al. Surgical treatment of recurrent thymoma: is it worthwhile? Eur J Cardiothorac Surg. 2016;49:327–32.CrossRefPubMed
17.
Zurück zum Zitat Shintani Y, Kanzaki R, Kusumoto H, Nakagiri T, Inoue M, Okumura M. Pleuropneumonectomy for a large thymoma with multiple pleural dissemination using median sternotomy followed by posterolateral thoracotomy. Surg Case Rep. 2015;1:75.CrossRefPubMedPubMedCentral Shintani Y, Kanzaki R, Kusumoto H, Nakagiri T, Inoue M, Okumura M. Pleuropneumonectomy for a large thymoma with multiple pleural dissemination using median sternotomy followed by posterolateral thoracotomy. Surg Case Rep. 2015;1:75.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Kashima J, Okuma Y, Murata, Watanabe K, Hosomi Y, Hishima T. Chemoradiotherapy for unresectable cases of thymic epithelial tumors: a retrospective study. J Thorac Dis. 2017;9:3911–8.CrossRefPubMedPubMedCentral Kashima J, Okuma Y, Murata, Watanabe K, Hosomi Y, Hishima T. Chemoradiotherapy for unresectable cases of thymic epithelial tumors: a retrospective study. J Thorac Dis. 2017;9:3911–8.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Hishida T, Nomura S, Yano M, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg. 2016;49(3): 835–841.CrossRefPubMed Hishida T, Nomura S, Yano M, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study. Eur J Cardiothorac Surg. 2016;49(3): 835–841.CrossRefPubMed
20.
Zurück zum Zitat Kanzaki R, Kanou T, Ose N, et al. Long-term outcomes of advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy followed by surgery: a 20-year experience. Interact Cardiovasc Thorac Surg. 2019;28:360–7.CrossRefPubMed Kanzaki R, Kanou T, Ose N, et al. Long-term outcomes of advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy followed by surgery: a 20-year experience. Interact Cardiovasc Thorac Surg. 2019;28:360–7.CrossRefPubMed
21.
Zurück zum Zitat Kobayashi Y, Fujii Y, Yano M, et al. Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action. Cancer. 2006;106:1901–7.CrossRefPubMed Kobayashi Y, Fujii Y, Yano M, et al. Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action. Cancer. 2006;106:1901–7.CrossRefPubMed
22.
Zurück zum Zitat Kimura T, Inoue M, Kadota Y, et al. The oncological feasibility and limitations of video-assisted thoracoscopic thymectomy for early-stage thymomas. Eur J Cardiothorac Surg. 2013;44:e214–8.CrossRefPubMed Kimura T, Inoue M, Kadota Y, et al. The oncological feasibility and limitations of video-assisted thoracoscopic thymectomy for early-stage thymomas. Eur J Cardiothorac Surg. 2013;44:e214–8.CrossRefPubMed
Metadaten
Titel
Long-Term Outcomes After Surgical Resection for Pleural Dissemination of Thymoma
verfasst von
Kenji Kimura, MD
Ryu Kanzaki, MD, PhD
Toru Kimura, MD, PhD
Takashi Kanou, MD, PhD
Naoko Ose, MD
Soichiro Funaki, MD, PhD
Masato Minami, MD, PhD
Yasushi Shintani, MD, PhD
Meinoshin Okumura, MD, PhD
Publikationsdatum
28.03.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07330-x

Weitere Artikel der Ausgabe 7/2019

Annals of Surgical Oncology 7/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.